Gastroenterology & Hepatology

Hepatocellular Carcinoma (HCC)

Researchers are invited to submit their abstracts for the "Hepatocellular Carcinoma (HCC)" track at GASTROENTEROLOGY-2024. This track will cover the latest advancements in the understanding, diagnosis, and treatment of HCC. Topics of interest include, but are not limited to:

• Molecular and genetic insights into HCC pathogenesis.
• Novel biomarkers for early detection and prognosis.
• Advances in imaging techniques and diagnostic tools.
• Emerging systemic therapies and combination treatments.
• Strategies for prevention and risk factor modification.

Attendees can expect to gain a deep understanding of the complex biology of HCC and the latest innovations in its clinical management. This track will feature presentations on cutting-edge research, including the identification of new therapeutic targets and the development of personalized treatment regimens. Experts will discuss advancements in early detection methods, the impact of novel systemic therapies, and the integration of multidisciplinary approaches in managing HCC. The track aims to facilitate knowledge exchange and foster collaborations to improve outcomes for patients with HCC.